Flupenthixol depot in the maintenance treatment of psychoses.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002090:Butyrophenones; D003692:Delayed-Action Preparations; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012008:Recurrence; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014966:Xanthenes / Q000008:administration & dosage / Q000627:therapeutic use*
D002090:Butyrophenones; D003692:Delayed-Action Preparations; D010879:Piperazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D000431:Ethanol; D005476:Fluphenazine